Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)
for Chronic Pruritus of Unknown Origin
Drug: Nemolizumab
25 locations incl. Birmingham
Sponsor: Galderma R&D
Sex: All·Age: 18+
Code: NCT07074977·Phase 2·Recruiting